Antonio Pinto
CTO Hospital(IT)Instituto Superior de Espinho(PT)Orthopaedic Trauma Association(US)Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"(IT)University of Minho(PT)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Viral-associated cancers and disorders, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma(2014)782 cited
- → Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study(2020)551 cited
- → Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma(2017)417 cited
- → AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma(2019)408 cited
- → The role of the EGFR signaling in tumor microenvironment(2007)358 cited
- → Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial(2007)